Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Quanterix Corporation - Common Stock (NQ:QTRX)

7.410 -0.150 (-1.98%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer’s Disease Diagnostic Information
From Quanterix
Via Business Wire
News headline image
Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces Commercialization of p-Tau 217 Test Kit
From Quanterix Corporation
Via Business Wire
Quanterix Corp. (NASDAQ: QTRX) Highlighted for Surprising Price Action
Via Investor Brand Network
News headline image
Earnings Scheduled For February 29, 2024 ↗
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Earnings Preview: Quanterix ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2024 ↗
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
News headline image
A Preview Of Quanterix's Earnings ↗
 
Via Benzinga
News headline image
Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
News headline image
Jeffrey Elliott Appointed to Quanterix’s Board of Directors
From Quanterix Corporation
Via Business Wire
News headline image
QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q2 2024 ↗
QTRX stock results show that Quanterix beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Earnings Outlook For Quanterix ↗
 
Via Benzinga
News headline image
Quanterix Releases Financial Results for the Second Quarter of 2024
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix To Report Second Quarter 2024 Financial Results
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
From Quanterix Corporation
Via Business Wire
News headline image
QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024 ↗
QTRX stock results show that Quanterix beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Quanterix Releases Financial Results for the First Quarter of 2024
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix To Report First Quarter 2024 Financial Results
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
From Quanterix
Via Business Wire
News headline image
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Present at Cowen’s 44th Annual Health Care Conference
From Quanterix Corporation
Via Business Wire
News headline image
Earnings Scheduled For February 26, 2024 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. 
Via Benzinga
News headline image
Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call
From Quanterix Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.